These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18448553)

  • 1. Chemotherapy in elderly patients with colorectal cancer.
    Köhne CH; Folprecht G; Goldberg RM; Mitry E; Rougier P
    Oncologist; 2008 Apr; 13(4):390-402. PubMed ID: 18448553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy of elderly patients with colorectal cancer].
    Landherr L; Nagykálnai T
    Magy Onkol; 2009 Jun; 53(2):97-105. PubMed ID: 19581175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of metastatic colorectal cancer.
    Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent results of irinotecan therapy in colorectal cancer].
    Láng I; Hitre E
    Magy Onkol; 2004; 48(4):281-8. PubMed ID: 15655572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current therapies for advanced colorectal cancer.
    Aggarwal S; Chu E
    Oncology (Williston Park); 2005 Apr; 19(5):589-95. PubMed ID: 15945340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in elderly patients with advanced colorectal cancer treated with capecitabine: a population-based analysis.
    Ho C; Ng K; O'Reilly S; Gill S
    Clin Colorectal Cancer; 2005 Nov; 5(4):279-82. PubMed ID: 16356306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of new agents in the treatment of colorectal cancer.
    Folprecht G; Köhne CH
    Oncology; 2004; 66(1):1-17. PubMed ID: 15031593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of advanced colorectal cancer in the elderly.
    Bruce C; Köhne CH; Audisio RA
    Eur J Surg Oncol; 2007 Dec; 33 Suppl 2():S84-7. PubMed ID: 18006266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cetuximab plus XELIRI or XELOX for first-line therapy of metastatic colorectal cancer.
    Moosmann N; Heinemann V
    Clin Colorectal Cancer; 2008 Mar; 7(2):110-7. PubMed ID: 18501070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic therapy for colorectal cancer.
    Meyerhardt JA; Mayer RJ
    N Engl J Med; 2005 Feb; 352(5):476-87. PubMed ID: 15689586
    [No Abstract]   [Full Text] [Related]  

  • 12. Current status of capecitabine in the treatment of colorectal cancer.
    Rothenberg ML
    Oncology (Williston Park); 2002 Dec; 16(12 Suppl No 14):16-22. PubMed ID: 12520635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Insight: Metastatic colorectal cancer--oral fluoropyrimidines and new perspectives in the adjuvant setting.
    Folprecht G; Köhne CH
    Nat Clin Pract Oncol; 2005 Nov; 2(11):578-87. PubMed ID: 16270098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy, which drugs and when.
    Koopman M; Punt CJ
    Eur J Cancer; 2009 Sep; 45 Suppl 1():50-6. PubMed ID: 19775604
    [No Abstract]   [Full Text] [Related]  

  • 15. Physical function and quality of life in frail and/or elderly patients with metastatic colorectal cancer treated with capecitabine and bevacizumab: an exploratory analysis.
    Ward P; Hecht JR; Wang HJ; Dichmann R; Liem AK; Chan D; Patel R; Hu EH; Tchekmedyian NS; Wainberg ZA; Naeim A
    J Geriatr Oncol; 2014 Oct; 5(4):368-75. PubMed ID: 25002322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: comparative outcomes from the 03-TTD-01 phase III study.
    Sastre J; Aranda E; Massutí B; Tabernero J; Chaves M; Abad A; Carrato A; Reina JJ; Queralt B; Gómez-España A; González-Flores E; Rivera F; Losa F; García T; Sanchez-Rovira P; Maestu I; Díaz-Rubio E
    Crit Rev Oncol Hematol; 2009 May; 70(2):134-44. PubMed ID: 19111473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based update of chemotherapy options for metastatic colorectal cancer.
    Damjanovic D; Thompson P; Findlay MP
    ANZ J Surg; 2004 Sep; 74(9):781-7. PubMed ID: 15379811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of treatment with chemotherapy and monoclonal antibodies for metastatic colorectal cancer in Western Europe.
    Zhao Z; Pelletier E; Barber B; Bhosle M; Wang S; Gao S; Klingman D
    Curr Med Res Opin; 2012 Feb; 28(2):221-9. PubMed ID: 22171947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cetuximab strongly enhances immune cell infiltration into liver metastatic sites in colorectal cancer.
    Inoue Y; Hazama S; Suzuki N; Tokumitsu Y; Kanekiyo S; Tomochika S; Tsunedomi R; Tokuhisa Y; Iida M; Sakamoto K; Takeda S; Ueno T; Yoshino S; Nagano H
    Cancer Sci; 2017 Mar; 108(3):455-460. PubMed ID: 28075526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of age on first-line systemic therapy in patients with metachronous metastases from colorectal cancer.
    Razenberg LG; van Erning FN; Pruijt HF; Ten Tije AJ; van Riel JM; Creemers GJ; Lemmens VE
    J Geriatr Oncol; 2017 Jan; 8(1):37-43. PubMed ID: 27659548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.